Joeri L Aerts
Overview
Explore the profile of Joeri L Aerts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laeremans T, Janssens A, Aerts J
Immunotherapy
. 2025 Feb;
17(2):133-145.
PMID: 39905963
Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells both play essential roles in controlling viral infections by eliminating virus-infected cells. Unlike CTLs, which require priming and activation by antigen-presenting...
2.
Dhaese S, den Roover S, Verbeke R, Aernout I, Meulewater S, Cosyns J, et al.
Mol Ther Nucleic Acids
. 2024 Dec;
35(4):102372.
PMID: 39618822
mRNA nanoparticles have been investigated in the context of prophylactic vaccination against HIV, but their effectivity has not been widely investigated in therapeutic vaccination. It has been suggested that a...
3.
den Roover S, Aerts J
Mol Ther Nucleic Acids
. 2024 Jun;
35(2):102226.
PMID: 38868362
No abstract available.
4.
Lara O, Janssen P, Mambretti M, De Pauw L, Ates G, Mackens L, et al.
Brain Behav Immun
. 2024 Mar;
118:275-286.
PMID: 38447884
xCT (Slc7a11), the specific subunit of the cystine/glutamate antiporter system x, is present in the brain and on immune cells, where it is known to modulate behavior and inflammatory responses....
5.
Schober R, Brandus B, Laeremans T, Iserentant G, Rolin C, Dessilly G, et al.
J Transl Med
. 2023 Nov;
21(1):791.
PMID: 37936122
Background: Combination antiretroviral therapy (cART) has dramatically extended the life expectancy of people living with HIV-1 and improved their quality of life. There is nevertheless no cure for HIV-1 infection...
6.
den Roover S, Aerts J
Mol Ther Nucleic Acids
. 2023 Aug;
33:545-547.
PMID: 37588687
No abstract available.
7.
Ramaut L, Moonen L, Laeremans T, Aerts J, Geeroms M, Hamdi M
Aesthet Surg J
. 2023 May;
43(9):NP696-NP703.
PMID: 37130047
Background: Mechanical isolation of the stromal vascular fraction (SVF) separates the stromal component from the parenchymal cells. Emulsification is currently the most commonly used disaggregation method and is effective in...
8.
Dos Santos Rodrigues B, Leroy K, Mihajlovic M, De Boever S, Vanbellingen S, Cogliati B, et al.
Arch Toxicol
. 2023 Mar;
97(6):1739-1751.
PMID: 36941454
Validated in vitro assays for testing non-genotoxic carcinogenic potential of chemicals are currently not available. Consequently, the two-year rodent bioassay remains the gold standard method for the identification of these...
9.
Laeremans T, den Roover S, Lungu C, Dhaese S, Gruters R, Allard S, et al.
NPJ Vaccines
. 2023 Mar;
8(1):29.
PMID: 36864042
Although natural killer (NK) cells have been studied in connection with dendritic cell (DC)-based vaccination in the field of cancer immunology, their role has barely been addressed in the context...
10.
Laeremans T, Dhaese S, Aernout J, Barbe K, Pannus P, Rutsaert S, et al.
AIDS
. 2022 Sep;
36(13):1761-1768.
PMID: 36172869
Objectives: Suppression of viral replication in patients on antiretroviral therapy (ART) is determined by plasma viral load (pVL) measurement. Whenever pVL reaches values below the limit of quantification, the qualitative...